Aurinia Pharmaceuticals AUPH Service Revenue — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's service revenue — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's service revenue — revenue?
- Aurinia Pharmaceuticals (AUPH) reported service revenue — revenue of $4.1M in Q1 2026.
- How has Aurinia Pharmaceuticals's service revenue — revenue changed year-over-year?
- Aurinia Pharmaceuticals's service revenue — revenue increased by 64.0% year-over-year, from $2.5M to $4.1M.
- What does service revenue — revenue mean?
- This metric represents the total gross revenue generated specifically from service-based activities or contractual support arrangements related to the company's pharmaceutical offerings. It captures income streams distinct from direct product sales, reflecting the company's ability to monetize ancillary services or specialized support programs. Monitoring this revenue stream provides insight into the diversification of the company's business model beyond core drug commercialization.